XEIA is a U.S.-focused venture capital firm investing in Human 3 themes, including brain-computer interfaces, neurotherapeutics, psychedelic medicine, longevity and health technology. It backs science-driven healthcare and life sciences startups across areas such as biotechnology, medical devices, pharmaceuticals, deep tech, AI-enabled health and hardware. Portfolio examples include Synchron, Lykos, Pepper Bio and Superpower, making it relevant for founders building frontier human health, neurotechnology or drug-discovery companies in the United States.